The Impact of Neut During Potassium Chloride Replacement on Pain and Incidence of Phlebitis

• Status: Terminated
• Trial end date: 2018-08-03
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to examine the impact of 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy for adult patients in a Medical/Surgical unit. Using a randomized controlled double blinded experimental study design, patients who are 21 years or older are alert, awake, and oriented at the time of enrollment and have been ordered peripheral intravenous potassium chloride replacement will be recruited from one Medical/Surgical during the first 24-48 hours of their admission.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Baptist Health South Florida

Criteria

Inclusion Criteria:

• admitted to the medical/surgical unit within the last 24 to 48 hours

• awake, alert, and oriented times three

• 21 years old and greater

• receiving first peripheral intravenous potassium chloride replacement therapy as ordered by physician or ARNP as part of care and regardless of research

• potassium level of 3.5 mmol/L or less.

Exclusion Criteria:

• patients who have been in the medical/surgical unit more than 48 hours.

• altered mental status defined as not being awake, alert, and oriented times three

• patients who already received intravenous potassium chloride replacement during the current admission and with the current IV access

• patients receiving intravenous potassium replacement therapy through a central line

• patients that are not ordered potassium replacement by physician or ARNP as part of their care while hospitalized.